Noveko Obtains $240,000 Order from Dufort & Lavigne, which will distribute its antimicrobial masks and hand sanitizers

MONTREAL, Sept. 15, 2011 /CNW Telbec/ - Noveko International Inc. (TSX: EKO) (the "Company") is pleased to announce that its subsidiary Noveko Inc. ("Noveko") has obtained an order worth $240,000 by Dufort & Lavigne Ltd. ("Dufort & Lavigne"), a Quebec business specializing in the distribution of medical supplies and equipment. This order is scheduled to be delivered within a few days. As distributor of the Company's products, Dufort & Lavigne will primarily ensure the Quebec-wide sale and promotion of Microban® hand sanitizers to medical and dental clinics as well as of Noveko™ antimicrobial masks to medical clinics and hospital centres.

"We are pleased we can now count on the expertise of Dufort & Lavigne. Its solid sales team and the size of its Quebec network will provide us with foremost access to healthcare niches in which we had little presence up to now. This initial collaboration fits with our strategy of partnering with leaders in their respective markets to stimulate the commercialization of our products," indicated Mr. Alain Bolduc, President and Chief Operating Officer of the Company.

"We selected Noveko as a supplier in order to expand our offering of value-added products and better serve the needs of our healthcare clients. Due to the innovative characteristics of Noveko's products, including their particularly useful antimicrobial properties in preventing the spread of germs, we are confident we will provide our specialized clients with new superior and effective solutions," added Mr. Yves Dufort, President of Dufort & Lavigne.

Founded in 1962, Dufort & Lavigne is a Quebec-wide business specializing in the distribution of medical supplies and equipment. More than 100 employees work primarily at the Montreal head office, and at its branch office located in Quebec City. Its sales force of 15 representatives and its 17 customer service employees ensure its presence throughout Quebec so as to meet the various needs of the medical, paramedical, dental, ambulance and other fields.

Noveko International Inc. offers innovative solutions in the environmental and medical fields worldwide. Through its subsidiaries, the Company specializes primarily in the following business segments: the development, manufacturing and marketing of derivative products from its patented antimicrobial filtration technologies, mainly air filters, surgical masks and respirators, as well as other products with antibacterial properties such as hand sanitizers - and the development, manufacturing and marketing of medical equipment, including portable real-time ultrasound scanners for use in human and veterinary medicine.

Certain statements set forth in this press release constitute forward-looking statements. In some cases, these statements are identified by the use of terms such as "may", "could", "might", "intend", "should", "expect", "project", "plan", "believe", "estimate" or other comparable variants. These statements are based on the information available at the time they are written, on assumptions made by management and on the expectations of management, acting in good faith, regarding future events, including those relating to economic conditions, fluctuations in exchange rates and operating expenses, and the absence of unusual events entailing supplementary expenditures. Although management considers these assumptions and expectations reasonable based on the information available at the time they are written, they could prove inaccurate. Forward-looking statements are also subject, by their very nature, to known and unknown risks and uncertainties such as those related to the industry, acquisitions, labor relations, credit, key officers, supply and product liability. The actual results of Noveko International Inc. could differ materially from those indicated or underlying these forward-looking statements. The reader is therefore recommended not to unduly rely on these forward-looking statements. Forward-looking statements do not reflect the potential impact of special items, any business combination or any other transaction that may be announced or occur subsequent to the date hereof. Unless otherwise required under securities laws, the Company does not intend and undertakes no obligation to update or revise the forward-looking statements to reflect new information, new events or new circumstances.


For further information:

Chantal Vennat, Director,
Investor Relations and Corporate Communications
Noveko International Inc.
Tel:  (514) 875-0606

Profil de l'entreprise


Renseignements sur cet organisme


Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .


Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.


Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.